Timothy Wu, who was the intellectual architect of much of the Biden administration’s competition policy, says the US has moved to an antitrust era that connects to democratic roots. Congressional intent assures its longevity, he told FTCWatch in a...
At first glance, the Federal Trade Commission’s complaint targeting the Amgen-Horizon deal seems ill-conceived and overbroad, but on second look there may be a hidden logic behind it. The history of the two companies could also become a factor in the analysis.
Current Issue: 590
FTC:WATCH No. 590